Wed. Jul 24th, 2024

The London Psychiatry Centre (TLPC) of Harley Street has partnered with leading provider of private medical services, LycaHealth, to offer repetitive Transcranial Magnetic Stimulation (rTMS), the ground-breaking and highly effective treatment for depression and anxiety, at Canary Wharf.

Rankings from the Organisation for Economic Co-operation and Development (OECD) show that Britain is one of the most depressed countries in Europe, and a recent survey showed that 34% of British workers are dealing with anxiety, depression or stress (PwC). This partnership brings the UK’s most experienced and pioneering team in rTMS to those who work in some of the most high pressured and stressful environments in the UK.

According the the Centre for Urban Design and Mental Health, city dwellers have a 40% increased risk of depression compared to those based outside the City. The partnership between TLPC and LycaHealth brings the innovative treatment of rTMS to the densely clustered business district of Canary Wharf, where over 100,000 people work.

rTMS is an effective, drug-free, non-invasive and pain-free treatment for depression. rTMS uses magnetic pulses to stimulate areas of the brain that regulate mood. Of 44 centres in the US and Australia that have published rTMS treatment results for treatment-resistant depression, the remission rate is 29%. There are no published treatment outcomes available in the UK other than those from TLPC. At TLPC, remission rate for treatment-resistant depression with rTMS is over 60%, with 74.2% of women and 58% of men recovering in an average of 4.3 weeks. These results were published in peer reviewed publications, including a presentation at The Royal College of Psychiatrists annual meeting in August 2017. The CQC stated in its inspection report that TLPC pioneered rTMS in the UK.

Dr Andy Zamar, Consultant Psychiatrist and Medical Director of TLPC, said: “We are delighted to announce our partnership with LycaHealth, and bring our unique expertise with the very high success rate in rTMS at Harley Street to Canary Wharf. Our partnership represents this vision by not only extending the tailormade care packages available to our clients, but by making innovative treatments for depression accessible for those based in the City and the East London area. LycaHealth’s cutting-edge facilities, personal care and commitment to exceeding expectations, combined with our dedication to excellence is a natural fit.”

TLPC was a national adviser to The National Institute for Health and Care Excellence (NICE) in issuing guidance on rTMS treatment for depression (IPG542) and has been described by the CQCas ‘innovative’ and ‘pioneering’ in their contribution to mental health treatment and research in the UK. The CQC highlighted in its inspection report that:
“Feedback from patients was very positive about the service, with some patients describing life changing treatments, following years of unsuccessful treatments elsewhere.”

“Staff provided innovative treatments to patients who could not easily access these elsewhere. They published papers in medical journals, and contributed to innovations in mental health provision in the UK.”

“Patients received a range of treatments which were not available in other settings, including repetitive transcranial magnetic stimulation, and external trigeminal nerve stimulation. Patients spoke highly of the impact of these treatments following unsuccessful previous treatments with medicines.”

By Editor